Side effect profile prediction – Tackling Big Pharma’s worst nightmare at an early stage
Correspondence: (Login to view email address)
- Novartis Institutes for Biomedical Research
- Document Type:
- Presentation
- Date:
- Received 18 October 2007 21:10 UTC; Posted 23 October 2007
- Subjects:
- Chemistry, Pharmacology, Bioinformatics
- Abstract:
This talk presents a method that predicts adverse side effects for molecules based on the chemical structure only. Also, targets for the compounds are predicted. Therefore it becomes possible to link a certain side effect to the interaction with a certain target through molecular space. Examples are given in the talk.
- Presented at:
- American Chemical Society Fall Meeting Boston 2007, 23 August 2007
Discussion
- Votes:
-
3 votes
- Comments:
-
0 comments
- (Login to share with a colleague)
Additional information
- License:
- This document is licensed to the public under the Creative Commons Attribution 2.5 License
- How to cite this document:
-
Scheiber, Josef. Side effect profile prediction – Tackling Big Pharma’s worst nightmare at an early stage. Available from Nature Precedings <http://dx.doi.org/10.1038/npre.2007.1239.1> (2007)
- Version info:
-
Other versions of this document in Nature Precedings
None.
Other versions of this document elsewhere on the web
None known.
